Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/2008
10/01/2008EP1973875A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
10/01/2008EP1841739A4 Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon2-yl)methyl] piperidine or its salt thereof via novel intermediate
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008CN101277969A Purification of imido-sugar and amino-sugar
10/01/2008CN101277948A Chemical process
10/01/2008CN100422151C Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/01/2008CN100422150C 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl)piperidine as glucosylceramide synthase (GCS) inhibitor
10/01/2008CN100422149C 2-hydroxymethyl-3,4,5-trihydroxy-1benzylpiperidine derivatives as inhibitors of glucosylceramide synthase (gcs)
10/01/2008CN100422148C Technology for industrialized production of hydrochloric acid multi-donepezil
10/01/2008CN100422147C Method of preparing compound of 0-substituted sulphonyl propylhomoserin class
09/2008
09/30/2008US7429604 Six-membered heterocycles useful as serine protease inhibitors
09/30/2008US7429593 Utilities of amide compounds
09/30/2008US7429586 Non-imidazole aryloxyalkylamines
09/30/2008US7429565 Antiviral phosphonate analogs
09/30/2008US7429278 N-(2-Thiophen-2-ylethyl)benzene-1,4-diamine; hair dye; very strong and sparingly selective coloration of keratin fibers, light fast, avoiding the degradation of the fibers
09/30/2008CA2303848C Substituted anilides
09/25/2008WO2008115263A2 Raf kinase inhibitors containing a zinc binding moiety
09/25/2008WO2008114971A1 Novel benzamide derivatives and process for the preparation thereof
09/25/2008WO2008113360A2 4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression
09/25/2008WO2008077810A3 Spiro-piperidine derivatives
09/25/2008US20080234485 1-Benzyl-4-[ (5,6-Dimethoxy-1-Indanon) -2-Yl] Methylpiperidine Hydrobromide or Crystals Thereof
09/25/2008US20080234334 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
09/25/2008US20080234333 Containing an acylated aminopiperidin-1-ylcarbonyl group, e.g., N1-1-(4-Benzoylamino-piperidine-1-carbonyl)-2,2-dimethyl-propyl]-2-butyl-N4-hydroxy-succinamide; for treating bacterial diseases
09/25/2008US20080234332 N,N'-diphenylureas substituted with groups including a hydroxamic acid or amide group, e.g., 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-(1-(hydroxyamino)-1-oxopropan-2-yl)picolinamide; inhibiting raf kinase and histone deacetylases; antiproliferative agents
09/25/2008US20080234324 Piperidine Derivatives as Gcs Inhibitors
09/25/2008US20080234321 1-ethyl-4-[3-fluoro-5-(methylsulfonyl)phenyl]piperidine; central nervous system disorders, Parkinson's disease, Parkinsonism, dyskinesias, including L-DOPA induced dyskinesias, dystonias, tics, tremor, Huntington disease
09/25/2008US20080234305 Novel Tetrahydropyridine Derivatives
09/25/2008US20080234281 2,3-Dihydrooxadiazoles such as 3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazole and 3-[3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazol-2-yl]-N,N-dimethylpropan-1-amine that are useful for treating cancer
09/25/2008US20080234274 Novel Compounds
09/25/2008US20080234271 Arylphenylamino- and Arylphenylether-Sulfide Derivatives, Useful For the Treatment of Inflammatory and Immune Diseases, and Pharmaceutical Compositions Containing Them
09/25/2008US20080234247 Heterocyclic analgesic compounds and methods of use thereof
09/25/2008CA2679260A1 Novel benzamide derivatives and process for the preparation thereof
09/24/2008EP1831152B1 Tetralin and indane derivatives and uses thereof as 5-ht antagonists
09/24/2008CN101273015A 3-cyclyl-2- (4-sulfamo yl-phenyl) -N-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
09/24/2008CN101273014A 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission
09/24/2008CN101270076A Method for preparing natural product (3S,9S)-Ciliatamides C
09/24/2008CN100420945C Method and device for detecting and insolating pharmacological compounds being contained in substance mixtures
09/24/2008CN100420673C S-(-)-amlodipine nicotinate and process for the preparation thereof
09/23/2008US7427636 Hepatitis C; toxicity, side effects reduction; improved pharmacological/pharmacokinetics properties; novel intermediates; increased cellular accumulation and retention of a drug compound, to improve their therapeutic and diagnostic value, comprising linking the compound to one or more phosphonate groups
09/23/2008US7427632 Factor Xa inhibitors
09/23/2008US7427612 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease
09/23/2008US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic
09/23/2008CA2418313C Piperidine derivatives and agent comprising the derivative as active ingredient
09/23/2008CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors
09/23/2008CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof
09/23/2008CA2310055C New urethanes, the thio and dithio analogues thereof,the salts thereof, pharmaceutical compositions containing these compounds and their use as well as process for preparing them
09/23/2008CA2198238C Piperidine derivatives as neurokinin antagonists
09/23/2008CA2173703C Synergistic stabilizer mixture
09/18/2008WO2008112022A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
09/18/2008WO2008111300A1 Novel diamide derivative
09/18/2008WO2008110794A1 Piperidinones useful in the treatment of inflammation
09/18/2008WO2008110793A1 Piperidinones useful in the treatment of inflammation
09/18/2008WO2008110008A1 Amide derivatives as calcium channel blockers
09/18/2008US20080227983 Piperidine derivatives and process for their production
09/18/2008US20080227823 (E)-4-(3-(3-bromo-4-fluorophenyl)acrylamido)-N-(2-(5-fluoro-1H-indol-3-yl)ethyl)piperidine-4-carboxamide; ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted T-type calcium channel activity
09/18/2008US20080227818 Neurokinin A receptor antagonist
09/18/2008US20080227817 N-{2-[((2S)-3-{[1-(4-chlorobenzyl)piperidin-4-yl]amino}-2-hydroxy-2-methylpropyl)oxy]-4-hydroxyphenyl}acetamide benzoate; used to inhibit Chemokine Receptor 1 in treating airways disease such as chronic obstructive pulmonary disease and asthma
09/18/2008US20080227814 Ethanolamine derivatives such as 6-hydroxy-1-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-(p-methylsulfonylphenyl)tetralin and 6-hydroxy-2-(p-(trifluoromethyl)phenyl)-3-(p-(2-(1-piperidinyl)ethoxy)benzoyl)benzothiophene; treating endometriosis and uterine leiomyoma.
09/18/2008US20080227780 Soluble epoxide hydrolase inhibitors
09/18/2008US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal
09/18/2008US20080226550 Mercaptan containing diagnostic agents for imaging malignant melanoma and distant metastases and rhenium (186Re, 188Re) therapeutic complexes for treating the same
09/18/2008CA2681118A1 Amide derivatives as calcium channel blockers
09/18/2008CA2680414A1 Piperidinones useful in the treatment of inflammation
09/18/2008CA2680412A1 Piperidinones useful in the treatment of inflammation
09/18/2008CA2680360A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
09/17/2008EP1968961A2 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
09/17/2008EP1968940A1 3 , 5-substitued piperidine compounds as renin inhibitors
09/17/2008EP1409477B1 Piperidine derivatives as nmda receptor antagonists
09/17/2008EP1392639B1 Pyruvate derivatives
09/17/2008CN101268049A Novel piperidine derivatives
09/17/2008CN101268046A Carboxamide derivatives as muscarinic receptor antagonists
09/17/2008CN101267816A Methods of treatment using hydroquinone ansamycins
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/16/2008US7425641 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
09/16/2008US7425631 Compounds and methods of use
09/16/2008US7425567 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates
09/16/2008US7425554 1,2-di(cyclic)substituted benzene compounds
09/16/2008US7425530 Stereoselective preparation of cyclic L-amino acids
09/16/2008CA2291170C Processes and intermediates for resolving piperidyl acetamide stereoisomers
09/12/2008WO2008109740A2 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
09/12/2008WO2008109591A1 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
09/12/2008WO2008107878A1 Novel quinonoid derivatives of cannabinoids and their use in the treatment of malignancies
09/12/2008WO2008107797A2 Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate
09/12/2008WO2008107320A1 Piperidine and piperazine derivatives used as anti-neoplasic agents or cell proliferation inhibitors
09/12/2008WO2008107176A1 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
09/11/2008US20080221334 Process for the Preparation of Onium Alkylsulfonates
09/11/2008US20080221333 Reacting potassium ethylmalonate with 2,6-dihydroxy-5-fluoro-3-cyanopyridine, producing ethyl 3-(2,6-dichloro-5-fluoro-3-pyridyl)-3-oxopropanoate; intermediate for the synthesis of quinolone antibiotics
09/11/2008US20080221332 Bis(1-octyloxyl-2,2,6,6-tetramethylpiperidin-4-yl)sebacate hydrochloride; ink jet ink
09/11/2008US20080221240 Functionalization of nanoscale articles including nanotubes and fullerenes
09/11/2008US20080221169 3-carboxy aryl sulfonamide compounds, which agonize or antagonize aquaporin channels; brain trauma, head trauma, eye disorder, pulmonary disorder, lung disease, vascular disease, kidney disease, heavy metal toxicity, Alzheimer's disease, tumor, and cancer
09/11/2008US20080221166 sleep disorders; (R)-2-[(S)1-(5-chloro-2-methoxy-phenyl)-3-(6-trifluoromethyl-pyridin-3-yl)-propylamino]-2-(4-fluoro-phenyl)-N-methyl-acetamide
09/11/2008US20080221164 Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use
09/11/2008US20080221162 to treat psychosomatic disorders, respiratory, allergic conditions, inflammatory conditions, cardiac conditions, gastrointestinal conditions, conditions of the urogenital system, and conditions of the cutaneous system
09/11/2008US20080221127 Ppar active compounds
09/11/2008US20080221106 Arylamine Ketones, Their Preparation Methods, The Pharmaceutical Composition Containing Them And Their Use
09/11/2008US20080221100 Soluble epoxide hydrolase inhibitors
09/10/2008EP1967190A1 Novel arylamidine derivative, salt thereof and antifungal agent containing those
09/10/2008EP1966187A1 Piperazine compounds useful as antagonists of c-c chemokines (ccr2b and ccr5) for the treatment of inflammatory diseases
09/10/2008EP1966148A1 Carboxamides
09/10/2008EP1966140A1 Process for synthesizing remifentanil
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 380